MicroRNA-655 attenuates the malignant biological behaviours of retinoblastoma cells by directly targeting PAX6 and suppressing the ERK and p38 MAPK signalling pathways

MicroRNA-655 attenuates the malignant biological behaviours of retinoblastoma cells by directly targeting PAX6 and suppressing the ERK and p38 MAPK signalling pathways
复制标题

DOI:
10.3892/or.2022.8385
复制
发表时间:
2022-08
期刊:
影响因子:
4.2
通讯作者:
Min Zhang-;Qiongxia Li;Y. Pan;Hui Wang;Gang Liu;Hui Yin
Min Zhang-;Qiongxia Li;Y. Pan;Hui Wang;Gang Liu;Hui Yin
中科院分区:
医学3区
文献类型:
--
作者:
Min Zhang-;Qiongxia Li;Y. Pan;Hui Wang;Gang Liu;Hui Yin

文献摘要

被引文献

相似文献

在这篇论文发表后,一位忧心忡忡的读者提请编辑注意,图2D、5D和6D中描绘流式细胞仪实验结果的各种面板中显示的数据与不同作者在其他文章中以不同形式出现的数据惊人地相似。由于上述文章中有争议的数据在提交给肿瘤学报告之前已经在其他地方发表,或者已经在考虑发表,编辑决定将这篇论文从杂志中撤回。有人要求提交人对这些关切作出解释,但编辑部没有收到答复。给读者带来的不便,编辑深表歉意。[肿瘤学报告39:2040年-2050年,2018年;DOI:10.3892/或.2018.6264]。
Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that data shown in various of the panels portraying the results from flow cytometric experiments in Fig. 2D, 5D and 6D were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 39: 2040‑2050, 2018; DOI: 10.3892/or.2018.6264].